Nije utvrđena bezbednost i efikasnost primene filgrastima kod pacijenata sa mijelodisplastičnim sindromom ili hroničnom mijeloidnom leukemijom.Long-term everyday administration is required to keep up scientific gain. Individualize the dosage determined by the patientâ?�™s medical system and also ANC. Inside the SCN postmarketing surveillanc